Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01822496
Brief Title: Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

First Submitted : April 1, 2013
First Submitted that Met QC Criteria : April 1, 2013
First Posted : April 2, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : October 12, 2018
Last Update Posted : October 15, 2018